UBC was engaged to assume responsibilities for a named-patient EAP by a sponsor company that is developing a product to treat a rare infectious disease.
Case Study – Expanded Access for Delivery of Treatment to Patients with Acute Adenovirus Infections through a Named Patient Program
Feb 17, 2020